FDA licensed plasma product collected by apheresis (in contrast to the whole blood-derived “recovered plasma“), usually intended for further manufacture. This plasma is used to prepare plasma derivatives (products such as human serum albumin and plasma protein fraction, various immune globulins such as Rh immune globulin, and various coagulation factor concentrates). Since source plasma donors may donate much more frequently than whole blood donors, this product FAR outweighs recovered plasma in terms of the amount used for plasma derivative manufacture. I should also mention that source plasma donors are often compensated financially, while whole blood donors whose plasma is labeled as recovered plasma are not compensated.